TP53 and hepatocellular carcinoma: FTSJ1 is a target of p53‐mediated repression in murine and human hepatocellular carcinoma (Holzer et al, 2019); WDR6 is linked to cell growth (Xie et al, 2007) and innate immunity (Sivan et al, 2015).